financetom
Business
financetom
/
Business
/
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
Mar 14, 2024 2:56 PM

Getty Images Holdings Inc. ( GETY ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the details. 

The Details: The company reported quarterly sales of $225.94 million which beat the analyst consensus estimate of $216.46 million by 4.38% and is a 2.39% decrease over sales of $231.47 million from the same period last year.

Getty Images ( GETY ) reported editorial revenue of $75.7 million, down 7.9% year over year, primarily due to the slowdown related to the Hollywood actors and writers strikes.

Annual subscription revenue as a percentage of total revenue grew to 54.5% up from 50.2% year-over-year.

“In a difficult 2023, Getty Images ( GETY ) continued to lay a strong foundation grounded in our core value propositions of helping our customers create at a higher level, saving them time and money and eliminating risk,” said Craig Peters, CEO of Getty Images ( GETY ).

Outlook: Getty Images ( GETY ) expects fiscal year 2024 revenue of between $928 million and $947 million, versus the $940.506 million consensus estimate.

“In 2023, we remained fiscally disciplined, generated healthy levels of free cash flow, and ended the year with a strong balance sheet,” said Jenn Leyden, CFO of Getty Images ( GETY ). “And as we look to 2024, we believe that we are well positioned to return to top-line growth while remaining fiscally disciplined to continue to deliver healthy profitability.”

GETY Price Action: According to Benzinga Pro, Getty Images ( GETY ) shares are trading up 8.74% after-hours at $5.60 at the time of publication Thursday.

Related News: What’s Going On With Bitcoin Miners Marathon Digital And Riot Platforms Stock?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment
Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment
Mar 14, 2024
05:38 PM EDT, 03/14/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said late Thursday the first patient has been dosed in a phase 1/2 study of NUV-1511 to treat advanced solid tumors. The company said the study will initially evaluate safety and tolerability, pharmacokinetic profile, and assess for indications of clinical activity in patients with advanced solid tumors who...
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
Mar 14, 2024
Getty Images Holdings Inc. ( GETY ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the details.  The Details: The company reported quarterly sales of $225.94 million which beat the analyst consensus estimate of $216.46 million by 4.38% and is a 2.39% decrease over sales of $231.47 million from the same period last year. Getty...
Madrigal Pharmaceuticals Gets FDA Approval for Liver Fibrosis Therapy
Madrigal Pharmaceuticals Gets FDA Approval for Liver Fibrosis Therapy
Mar 14, 2024
05:36 PM EDT, 03/14/2024 (MT Newswires) -- Madrigal Pharmaceuticals ( MDGL ) received the US Food and Drug Administration's accelerated approval of Rezdiffra for treating adults with noncirrhotic nonalcoholic steatohepatitis and moderate to advanced liver fibrosis, the company said Thursday. Rezdiffra, which is a once-daily oral therapy, was approved in combination with diet and exercise, the company said. The approval...
--Caleres Keeps Regular Quarterly Cash Dividend at $0.07 a Share, Payable April 12 to Holders of Record March 28
--Caleres Keeps Regular Quarterly Cash Dividend at $0.07 a Share, Payable April 12 to Holders of Record March 28
Mar 14, 2024
05:38 PM EDT, 03/14/2024 (MT Newswires) -- Price: 38.5, Change: +0.16, Percent Change: +0.42 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved